- sales@syndicatedanalytics.com
- +1-213-316-7435
GCC Generic Injectables Market by Therapeutic Area (Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition and Cardiovascular) by Container (Vials, Ampoules, Premix and Prefilled Syringes) and Distribution Channel (Hospitals and Retail Pharmacy Stores): Industry Analysis, Trends, Growth and Forecast 2019-2024
GCC Generic Injectables Market Overview:
The GCC generic injectables market was worth US$ 438 Million in 2018, expanding at a CAGR of 14% during 2011-2018. The market is projected to register a CAGR of 12% during 2019-2024, reaching US$ 865 Million by 2024. The GCC generic injectables market is currently exhibiting a healthy growth. Generic injectables are biologics that provide treatment of various drugs and has the same components as their branded versions. The required regulations and manufacturing processes of these injectables are similar to those of their branded counterparts. Additionally, the R&D required for these injectables do not require huge investments. The production of generic injectables has been an advantage for several manufacturers as governments in various countries of GCC region have promoted the same because of the benefits it offers and its low-cost. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited erosion and high profit margins. These medicines are becoming popular on account of several other factors which include expiration of patents of popular drugs, increasing prevalence of chronic and lifestyle diseases, and ageing population. Additionally, the cost of generic injectables is much lower as compared to its counterparts, making it highly affordable for the patients.
GCC Generic Injectables Market Segment Insights:
The report has assessed the GCC generic injectables market. The report has further examined the market based on therapeutic area including, oncology, anaesthesia, anti-infectives, parenteral nutrition and cardiovascular. On the basis of container covering, vials, ampoules, premix and prefilled syringes. On the basis of distribution channel including, hospitals and retail pharmacy stores. On a regional basis, the report examines the generic injectables market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. An evaluation of the competitive landscape has also been provided with the details of the key players operating in the GCC generic injectables market.
Highlights of the GCC Generic Injectables Market Report:
- Historical and current scenario
- Trends and developments
- Market forecast
- Price analysis and forecast
- Porter’s five forces analysis
- SWOT analysis
- Value chain analysis
Key Market Segments:
The GCC generic injectables market has been analysed as followed:
Segmentation by Therapeutic Area:
- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral Nutrition
- Cardiovascular
Based on therapeutic areas, oncology represents the leading segment for generic injectables, accounting for the majority of the total market share. Rising cases of cancer along with patent expiry of oncology drugs are boosting the demand for generic injectables
Segmentation by Container:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
According to the report, vials represent the most popular container type, holding the largest share. Vials are plastic or glass vessels which can be reused to store liquid after cleaning, and offer correct and explicit mark signs that give a visual indicator of the left-over quantity.
Segmentation by Distribution Channel:
- Hospitals
- Retail Pharmacy Stores
On the basis of distribution channels, the market has been bifurcated into hospitals and retail pharmacy stores, wherein hospitals exhibit a clear dominance. Generic injectables cannot be traded or administered without medical assistance owing to which they are mostly available in hospitals.
Segmentation by Country:
- Saudi Arabia
- United Arab Emirates
- Qatar
- Kuwait
- Oman
- Bahrain
Region-wise, Saudi Arabia represents the dominant market, accounting for the majority of the total market share. Domestic generic injectable manufacturers in the region are collaborating with global and regional pharma players to expand their manufacturing capacity.
Report Customisation:
The GCC generic injectables market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2 Research Methodology
2.1 Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3 Executive Summary
4 Global Generic Drug Market
4.1 Historical Market Trend
4.2 Market Segmentation by Region
4.3 Market Outlook
4.4 Major Players
5 GCC Generic Drug Market Drug Delivery
5.1 Oral
5.2 Injectables
5.3 Dermal/Topical
5.4 Inhalers
6 GCC Generic Injectables Market
6.1 Industry Overview
6.2 Key Industry Developments
6.3 Market Trends
6.3.1 Key Market Indicators
6.3.2 Historical Market Trends
6.3.3 Market Outlook
7 GCC Generic Injectables Market Segmentation by Country
7.1 Saudi Arabia
7.1.1 Historical Market Trends
7.1.2 Market Outlook
7.2 United Arab Emirates
7.2.1 Historical Market Trends
7.2.2 Market Outlook
7.3 Qatar
7.3.1 Historical Market Trends
7.3.2 Market Outlook
7.4 Kuwait
7.4.1 Historical Market Trends
7.4.2 Market Outlook
7.5 Oman
7.5.1 Historical Market Trends
7.5.2 Market Outlook
7.6 Bahrain
7.6.1 Historical Market Trends
7.6.2 Market Outlook
8 GCC Generic Injectables Market Segmentation by Therapeutic Area
8.1 Oncology
8.1.1 Historical Market Trends
8.1.2 Market Outlook
8.2 Anaesthesia
8.2.1 Historical Market Trends
8.2.2 Market Outlook
8.3 Anti-infectives
8.3.1 Historical Market Trends
8.3.2 Market Outlook
8.4 Parenteral Nutrition
8.4.1 Historical Market Trends
8.4.2 Market Outlook
8.5 Cardiovascular
8.5.1 Historical Market Trends
8.5.2 Market Outlook
9 GCC Generic Injectables Market Segmentation by Container
9.1 Vials
9.1.1 Historical Market Trends
9.1.2 Market Outlook
9.2 Ampoules
9.2.1 Historical Market Trends
9.2.2 Market Outlook
9.3 Premix
9.3.1 Historical Market Trends
9.3.2 Market Outlook
9.4 Prefilled Syringes
9.4.1 Historical Market Trends
9.4.2 Market Outlook
10 GCC Generic Injectables Market Segmentation by Distribution Channel
10.1 Hospitals
10.1.1 Historical Market Trends
10.1.2 Market Outlook
10.2 Retail Pharmacy Stores
10.2.1 Historical Market Trends
10.2.2 Market Outlook
11 GCC Generic Injectables Industry: Market Dynamics
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 GCC Generic Injectables Industry: Value Chain Analysis
12.1 Overview
12.2 Research and Development
12.3 Raw Material Suppliers
12.4 Inbound Logistics
12.5 Production
12.6 Marketing
12.7 Outbound Logistics
12.8 Consumers
13 GCC Generic Injectables Industry: Porter’s Five Forces Analysis
13.1 Overview
13.2 Threat of New Entrants
13.3 Threat of Substitutes
13.4 Bargaining Power of Buyers
13.5 Bargaining Power of Suppliers
13.6 Intensity of Rivalry
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Key Success Factors
15 Key Player Profiles
List of Figures
Figure 1: Global: Generic Drug Market: Sales Value (in Billion US$), 2011-2018
Figure 2: Global: Generic Drug Market: Segmentation by Region (in %), 2018
Figure 3: Global: Generic Drug Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 4: GCC: Generic Drug Market : Sales Value (in Billion US$), 2011-2018
Figure 5: GCC: Generic Drug Market: Segmentation by Drug Delivery (in %), 2018
Figure 6: GCC: Generic Drug Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 7: GCC: Generic Injectables Market: Sales Value (in Million US$), 2011-2018
Figure 8: GCC: Generic Injectables Market Outlook: Sales Value (in Billion US$), 2019-2024
Figure 9: GCC: Generic Injectables Market: Segmentation by Country (in %), 2018
Figure 10: GCC: Generic Injectables Market: Segmentation by Therapeutic Area (in %), 2018
Figure 11: GCC: Generic Injectables Market: Segmentation by Container (in %), 2018
Figure 12: GCC: Generic Injectables Market: Segmentation by Distribution Channel (in %), 2018
Figure 13: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 14: Saudi Arabia: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 15: United Arab Emirates: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 16: United Arab Emirates: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 18: Qatar: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 19: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 20: Kuwait: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 21: Oman: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 22: Oman: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 23: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 24: Bahrain: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 25: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2011 & 2018
Figure 26: GCC: Generic Injectables (Oncology) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 27: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2011 & 2018
Figure 28: GCC: Generic Injectables (Anaesthesia) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 29: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2011 & 2018
Figure 30: GCC: Generic Injectables (Anti-infectives) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 31: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2011 & 2018
Figure 32: GCC: Generic Injectables (Parenteral Nutrition) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 33: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2011 & 2018
Figure 34: GCC: Generic Injectables (Cardiovascular) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 35: GCC: Generic Injectables (Vials) Market: Sales Value (in Million US$), 2011 & 2018
Figure 36: GCC: Generic Injectables (Vials) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 37: GCC: Generic Injectables (Ampoules) Market: Sales Value (in Million US$), 2011 & 2018
Figure 38: GCC: Generic Injectables (Ampoules) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 39: GCC: Generic Injectables (Premix) Market: Sales Value (in Million US$), 2011 & 2018
Figure 40: GCC: Generic Injectables (Premix) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 41: GCC: Generic Injectables (Prefilled Syringes) Market: Sales Value (in Million US$), 2011 & 2018
Figure 42: GCC: Generic Injectables (Prefilled Syringes) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 43: GCC: Generic Injectables (Hospitals) Market: Sales Value (in Million US$), 2011 & 2018
Figure 44: GCC: Generic Injectables (Hospitals) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 45: GCC: Generic Injectables (Retail Pharmacy Stores) Market: Sales Value (in Million US$), 2011 & 2018
Figure 46: GCC: Generic Injectables (Retail Pharmacy Stores) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 47: GCC: Generic Injectables Industry: Market Dynamics
Figure 48: GCC: Generic Injectables Industry: Value Chain Analysis
Figure 49: GCC: Generic Injectables Market: Porter’s Five Forces Analysis
List of Tables
Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 2: GCC: Generic Injectables Market Outlook: Segmentation by Country (in Million US$), 2019-2024
Table 3: GCC: Generic Injectables Market Outlook: Segmentation by Therapeutic Area (in Million US$), 2019-2024
Table 4: GCC: Generic Injectables Market Outlook: Segmentation by Container (in Million US$), 2019-2024
Table 5: GCC: Generic Injectables Market Outlook: Segmentation by Distribution Channel (in Million US$), 2019-2024
Table 6: GCC: Generic Injectables Market Structure
Table 7: GCC: Generic Injectables Market: Key Players
Special Prices
- Academic Institutes
- Government Agencies
- Nonprofit Organizations
- For more information, feel free to contact us.
Syndicated Analytics provides special pricing for:
Related Reports
The report offers an in-depth roadmap or setting up a Garbage Bags manufacturing plant covering the essential techno-commercial aspects
Sanitary Napkins Prefeasibility Analysis Report 2019
The report offers an in-depth roadmap or setting up a Sanitary Napkins manufacturing plant covering the essential techno-commercial aspects.
The report offers an in-depth roadmap or setting up a Surgical Gloves manufacturing plant covering the essential techno-commercial aspects
Linear Alkylbenzene Sulfonate Production Cost Analysis Report 2019
This production cost analysis report by Syndicated Analytics is the result of comprehensive examination of the Linear Alkylbenzene Sulfonate manufacturing process
The GCC Healthcare Information Software Market was worth US$ XX Billion in 2018, expanding at a CAGR of X% during 2011-2018. The market is projected to register a CAGR of X% during 2019-2024, reaching US$ XX Billion by 2024.